COAGULATION FACTOR XIII - ANVISA Registration 81816720029

Access comprehensive regulatory information for COAGULATION FACTOR XIII in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81816720029 and manufactured by TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAGNOSTICA STAGO S.A.S., SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.